Publications by authors named "Suoqin Shi"
Biomed Pharmacother
June 2024
Article Synopsis
- Cancer ranks as one of the deadliest diseases globally, with advanced metastatic carcinoma leading in mortality, highlighting the urgent need for new targeted therapies.
- Researchers developed a novel antibody fusion protein, 57103, which effectively targets multiple receptors and exhibited significant anti-cancer effects in vitro by suppressing the growth, migration, and invasion of renal cancer cells.
- In animal studies, 57103 demonstrated the ability to inhibit tumor growth and promote cancer cell death while also improving immune responses, indicating its potential as a treatment for metastatic renal carcinoma or other cancers that overexpress PDL1.
